Amgen Inc

Change company Symbol lookup

Select an option...

AMGN Amgen Inc

BAC Bank of America Corp

CLOV Clover Health Investments Corp

HRL Hormel Foods Corp

DD Dupont De Nemours Inc

PSRU Valiant Eagle Inc

CRM Salesforce.Com Inc

VLYPP Valley National Bancorp

FEMKX Fidelity® Emerging Markets Fund

XPEV Xpeng Inc

Go

ROCKVILLE, MD / ACCESSWIRE / March 1, 2021 / Fifty years ago, a small group of friends created a nonprofit that in its first year saved the lives of 79 people with kidney failure, and a mission was born. This Kidney Month, the American Kidney Fund...(Accesswire)

Positive full results from the pivotal NAVIGATOR Phase III trial showed AstraZeneca and Amgen's tezepelumab demonstrated a statistically significant and clinically meaningful(1) reduction in the annualized asthma exacerbation rate (AAER) in severe...(BusinessWire)

Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive full results from the pivotal NAVIGATOR Phase 3 trial, which showed the potential of tezepelumab to be a first-in-class medicine in severe asthma. When added to standard of care (SoC)...(PR Newswire)

ROCKVILLE, MD / ACCESSWIRE / February 25, 2021 / The American Kidney Fund (AKF) today announced the 2021 class of Members in its Corporate Membership Program. Corporate Members form a strategic partnership with AKF, helping AKF to fight on all...(Accesswire)

The global wearable injectors market size is projected to reach USD 15.66 Billion by 2028 at a CAGR of 11.2% over the forecast period, according to latest analysis by Emergen Research. This steady growth can be attributed to increasing challenges...(Globe Newswire)

Amgen (NASDAQ:AMGN) will present at the Cowen 41st Annual Virtual Healthcare Conference at 12:50 p.m. ET on Thursday, March 4, 2021. Murdo Gordon, executive vice president of Global Commercial Operations and Peter H. Griffith, executive vice...(PR Newswire)

The "Global BiTE Antibodies Market , Price, Sales & Clinical Trials Insight 2025" report has been added to ResearchAndMarkets.com's offering. This report reviews about the wide spread applications of the market and how it has been able to...(Globe Newswire)

Amgen (NASDAQ:AMGN) will host a webcast call for the investment community in conjunction with the 2021 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting on Friday, Feb. 26, at 1:00 p.m. ET. David M. Reese, M.D., executive...(PR Newswire)

The North America osteoporosis treatment market size is expected to gain momentum by reaching USD 8.29 billion by 2027 while exhibiting a CAGR of 6.6% between 2020 and 2027. This is attributable to the increasing prevalence of osteoporosis and the...(Globe Newswire)

Toronto, Ontario--(Newsfile Corp. - February 18, 2021) - Universal PropTech Inc. (TSXV: UPI) ("UPI" or the "Company") is pleased to announce that it has completed an investment in ISBRG Corp. ("ISBRG") for a minority interest, and secured agency...(Newsfile)

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review for sotorasib for the treatment of patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC)...(PR Newswire)

Veeva Systems (NYSE: VEEV) today announced that more than 250 organizations are using Veeva Vault RIM applications for end-to-end regulatory information management. A growing number of emerging biotechs and enterprise companies, including 12 of the...(BusinessWire)

Veeva Systems (NYSE: VEEV) today announced that more than 250 organizations are using Veeva Vault RIM applications for end-to-end regulatory information management. A growing number of emerging biotechs and enterprise companies, including 12 of the...(BusinessWire)

AmMax Bio, Inc. ("AmMax"), a private clinical-stage biopharmaceutical company focused on developing first-in-class or best-in-class treatments with its proprietary dual anti-inflammatory/anti-fibrotic therapeutic platform targeting the...(BusinessWire)

The "I-O Therapy Combinations Spurring Growth of the Global Immuno-oncology Market" report has been added to ResearchAndMarkets.com's offering. This study explores the global immuno-oncology (I-O) market's evolution from 2020 to 2025. An extensive...(BusinessWire)

The "Europe Cell and Gene Therapy Market - Industry Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Europe Cell and...(Globe Newswire)

The global leukemia therapeutics market size is projected to reach USD 27.78 billion by 2027, exhibiting a CAGR of 8.1% during the forecast period. The increasing demand for enhanced treatments for blood cancers amid the COVID-19 pandemic will...(Globe Newswire)

Upholds decision by U.S. District Court to invalidate Amgen's patent claims directed to PCSK9 antibodies Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the United States Court of Appeals for the Federal Circuit upheld the...(PR Newswire)

The "Erythropoietin (EPO) Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need...(BusinessWire)

Amgen (NASDAQ:AMGN) today announced that Greg Friberg, vice president and global oncology therapeutic area head at Amgen, will participate in a fireside chat as part of the Guggenheim Healthcare Talks 2021 Oncology Day on Friday, Feb. 12 at 12:30...(PR Newswire)